CN101991747A - Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis - Google Patents
Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis Download PDFInfo
- Publication number
- CN101991747A CN101991747A CN2009101692780A CN200910169278A CN101991747A CN 101991747 A CN101991747 A CN 101991747A CN 2009101692780 A CN2009101692780 A CN 2009101692780A CN 200910169278 A CN200910169278 A CN 200910169278A CN 101991747 A CN101991747 A CN 101991747A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- preparation
- rhizoma
- ascitesduetocirrhosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis, which comprises the selected Chinese medical herbs in parts by weight: Chinese angelica, the rhizome of chuanxiong, tuckahoe, yam, the root of red-rooted salvia, astragalus root, oriental wormwood, giant knot weed, bighead atractylodes rhizome, the rhizome of oriental water plantain, Chinese holly leaf and trogopterus dung. The preparation comprises a tablet, a powder, a capsule, a pulvis and an oral liquid preparation prepared by applying the traditional preparation process or modern preparation process. The Chinese medical herbs are combined to have the effects of clearing heat, detoxicating, dispelling the dampness, controlling deficiency of vital energy and deficiency of blood, smoothing the liver, harmonizing the stomach, promoting blood circulation, removing blood stasis, and protecting the liver. The Chinese material medical preparation improves the immunity through oral administration, and has better treatment effect on hepatitis B, cirrhosis and ascitesduetocirrhosis. Found through clinical practice, the invention has the advantages of rapid effect taking, remarkable treatment effect, good tolerance, low cost and no any toxic and side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation that is used for the treatment of hepatitis B, cirrhotic ascites.
Background technology
Liver cirrhosis is the principal disease that causes ascites, and in a single day ascites appear in liver cirrhosis patient, indicates that sclerosis has entered the compensatory phase of mistake.The main cause that ascites forms is: portal venous pressure rising, albumin reduction, the minimizing of kidney effective circulating blood volume, endocrine dysfunction etc.
In the prior art, the measure of treatment cirrhotic ascites mainly contains doctor trained in Western medicine, the traditional Chinese medical science, combination of Chinese and Western medicine three major types.Generally speaking, doctor trained in Western medicine effect a permanent cure deficiency, take stopgap measures and have a surplus, expense elasticity is very big, long-term effect is poor, traditional Chinese medical science treating both the principal and secondary aspects of a disease, expense elasticity is little, medical skill is uneven, long-term effect is better; The combination of Chinese and Western medicine is learnt from other's strong points to offset one's weaknesses, and control is supported and taken into account, and expense is moderate, and long-term effect is more satisfactory.
The Chinese patent publication number be CN101428114's " a kind of medicine for the treatment of chronic viral hepatitis B, liver cirrhosis and hepatic ascites ", make by Chinese herbal medicine such as Radix Polygoni Multiflori, Radix Angelicae Sinensis, Rhizoma Chuanxiong, the Radix Paeoniae Alba, the Rhizoma Atractylodis Macrocephalae, Rhizoma Coptidis, Radix Rehmanniae, Radix Glycyrrhizae and Radix Scutellariaes, hepatitis B, liver cirrhosis and hepatic ascites are had good curative effect.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine preparation with heat-clearing and toxic substances removing dampness removing, deficiency of vital energy blood deficiency, soothing liver-QI stomach function regulating, blood circulation promoting and blood stasis dispelling, hepatoprotective effect, good at the therapeutic effect of hepatitis B, liver cirrhosis, hepatic ascites.
The present invention has adopted following technical scheme:
Crude drug and the composition by weight thereof chosen are respectively: 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 15 parts in Poria, 30 parts of Rhizoma Dioscoreaes, 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of the Radixs Astragali, 20 parts of Herba Artemisiae Scopariaes, 30 parts of Rhizoma Polygoni Cuspidati, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Alismatis, 20 parts of Folium Mahoniaves, 15 parts of Oletum Trogopteroris; Its preparation comprises pill, powder, capsule, powder, the oral liquid formulations that utilization conventional formulation technology or modern preparation process are made.
The crude drug that the present invention chooses is pure Chinese crude drug, Radix Angelicae Sinensis: enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping.Poria: detoxifcation, dampness removing, sharp joint.Rhizoma Dioscoreae: supplementing QI and nourishing YIN, spleen reinforcing lung kidney, treating spontaneous emission and leukorrhagia.Radix Salviae Miltiorrhizae: blood circulation promoting and blood stasis dispelling, the removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, the Radix Astragali: tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, inducing diuresis to remove edema.Herba Artemisiae Scopariae: clearing away heat-damp and promoting diuresis, jaundice eliminating.Rhizoma Polygoni Cuspidati: the analgesic therapy of invigorating blood circulation, expelling wind and removing dampness, heat-clearing and toxic substances removing, preventing phlegm from forming and stopping coughing, relieving constipation by purgation.The Rhizoma Atractylodis Macrocephalae: air making-up and spleen enlivening, the dampness diuretic, hidroschesis, antiabortive.Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen expels the heat-evil.Oletum Trogopterori: invigorating blood circulation pain, removing stasis to stop bleeding is separated the snakeworm poison.
Selected medical material gathers the effect of heat-clearing and toxic substances removing dampness removing, deficiency of vital energy blood deficiency, soothing liver-QI stomach function regulating, blood circulation promoting and blood stasis dispelling, hepatoprotective altogether.Improved human body immune function by for oral administration,, had excellent curative at hepatitis B, liver cirrhosis, hepatic ascites.Find through clinical practice, the present invention have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
Obvious, without any side effects through clinical practice discovery, curative effect of the present invention, treat with low costly, cure the advantage that the back does not have recurrence.
Use Chinese medicine preparation of the present invention, patient's 357 examples are accepted in outpatient service for medical treatment, cure rehabilitation 328 examples.The rehabilitation standard is: ascites disappears to the greatest extent, does not see recurrence after the healing.
Model case wherein:
Case 1: Mrs Yan, 46 years old, people from Dengfeng City, the enlargement of patient's abdominal part, constipation, deep pulse and profound.Obeyed pellet-formulation of the present invention 14 days, abdomen is swollen to disappear, and the urine amount increases.Serve on for 4 weeks subsequently, ascites disappears to the greatest extent, does not see recurrence after the healing.
Case 2: Mrs Li, 42 years old, people from Xinmi City was diagnosed as cirrhotic ascites.Take 8 weeks of capsule preparations of the present invention, transference cure, it is normal that liver function test recovers, and cures after 1 year and pay a return visit, and do not have recurrence.
The specific embodiment
Realize a kind of Chinese medicine preparation that is used for the treatment of hepatitis B, cirrhotic ascites of the present invention, crude drug and the composition by weight thereof chosen are respectively: 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 15 parts in Poria, 30 parts of Rhizoma Dioscoreaes, 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of the Radixs Astragali, 20 parts of Herba Artemisiae Scopariaes, 30 parts of Rhizoma Polygoni Cuspidati, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Alismatis, 20 parts of Folium Mahoniaves, 15 parts of Oletum Trogopteroris; Its preparation comprises pill, powder, capsule, powder, the oral liquid formulations that utilization conventional formulation technology or modern preparation process are made.
Claims (1)
1. Chinese medicine preparation that is used for the treatment of hepatitis B, cirrhotic ascites, it is characterized in that: crude drug and the composition by weight thereof chosen are respectively: 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Chuanxiongs, 15 parts in Poria, 30 parts of Rhizoma Dioscoreaes, 30 parts of Radix Salviae Miltiorrhizaes, 30 parts of the Radixs Astragali, 20 parts of Herba Artemisiae Scopariaes, 30 parts of Rhizoma Polygoni Cuspidati, 15 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Alismatis, 20 parts of Folium Mahoniaves, 15 parts of Oletum Trogopteroris; Its preparation comprises pill, powder, capsule, powder, the oral liquid formulations that utilization conventional formulation technology or modern preparation process are made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101692780A CN101991747A (en) | 2009-08-26 | 2009-08-26 | Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101692780A CN101991747A (en) | 2009-08-26 | 2009-08-26 | Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101991747A true CN101991747A (en) | 2011-03-30 |
Family
ID=43782823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101692780A Pending CN101991747A (en) | 2009-08-26 | 2009-08-26 | Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101991747A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727681A (en) * | 2012-06-20 | 2012-10-17 | 安徽中医学院 | Application of angelica peony powder in preparation of drugs for treating cirrhosis ascites |
| CN103285211A (en) * | 2013-05-22 | 2013-09-11 | 张永 | Traditional Chinese medicine particles for treating pathological obesity and preparation method |
| CN103417629A (en) * | 2013-08-28 | 2013-12-04 | 陈国勇 | Traditional Chinese medicine for treating hepatitis B liver cirrhosis |
| CN104922385A (en) * | 2015-06-30 | 2015-09-23 | 吕超 | Traditional Chinese medicine particulate agent for treating hepatic ascites |
-
2009
- 2009-08-26 CN CN2009101692780A patent/CN101991747A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727681A (en) * | 2012-06-20 | 2012-10-17 | 安徽中医学院 | Application of angelica peony powder in preparation of drugs for treating cirrhosis ascites |
| CN103285211A (en) * | 2013-05-22 | 2013-09-11 | 张永 | Traditional Chinese medicine particles for treating pathological obesity and preparation method |
| CN103417629A (en) * | 2013-08-28 | 2013-12-04 | 陈国勇 | Traditional Chinese medicine for treating hepatitis B liver cirrhosis |
| CN103417629B (en) * | 2013-08-28 | 2015-06-03 | 陈国勇 | Traditional Chinese medicine for treating hepatitis B liver cirrhosis |
| CN104922385A (en) * | 2015-06-30 | 2015-09-23 | 吕超 | Traditional Chinese medicine particulate agent for treating hepatic ascites |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103127378B (en) | Chinese medicinal composition for treating rheumatic heart disease | |
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN102430079B (en) | Traditional Chinese medicine composite for treating stranguria | |
| CN102188560A (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN102048961A (en) | Traditional Chinese medicine preparation for treating hypertension | |
| CN101991747A (en) | Chinese material medical preparation for treating hepatitis B and ascitesduetocirrhosis | |
| CN102048900A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
| CN102048899A (en) | Traditional Chinese medicine preparation for treating impotence | |
| CN103211980B (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN104173565A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN1311032A (en) | Tea for reducing weight and lowering fat and its preparing method | |
| CN103550548B (en) | A kind of Chinese medicine composition for the treatment of constipation | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN101683446A (en) | Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat | |
| CN103028076B (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
| CN102988632B (en) | Chinese medicinal composition for treating oedematous | |
| CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
| CN105233208A (en) | Traditional Chinese medicine preparation for treating heart failure | |
| CN104645223A (en) | Traditional Chinese medicine composition for treating sciatica | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| CN103656565A (en) | Drug for treating Qi and Yin deficiency type myocardial infarction | |
| CN101757466A (en) | Traditional Chinese medicine for deficiency of vital energy and headache | |
| CN103800749A (en) | Traditional Chinese medicine composition for treating deficiency of heart-yin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110330 |